EBITDA Margin ratio Analysis of Janux Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-717.76
Period Ending - Dec-22
Very Poor EBITDA Margin
-747.81
Growth
4.02 %
Trailing Twelve Months EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-992.56
Most recent Quarter EBITDA Margin
Period Ending - Mar-24
Very Poor EBITDA Margin
-1610.30
EBITDA Margin Analysis of Janux Therapeutics Inc
| Ebitda Margin Ratio of Janux Therapeutics Inc with value of -992.56 means that its operating expenses are Higher in relation to total revenue in trailing twelve months. |
| Ebitda Margin Ratio of Janux Therapeutics Inc with value of -1610.30 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Mar-24. |
| EBITDA Margin Ratio of JANX has grown by 4.02 % Compared to previous Financial Year. |
| EBITDA Margin Ratio of JANX trending up for at least three Years. |
| EBITDA Margin Ratio with value of -1727.63 was lowest in Year Dec-20 in last Five Years. |
| Latest EBITDA Margin Ratio with value of -717.76 is Greater than Average EBITDA Margin of -818.30 in last five years. |
| Ebitda Margin of Janux Therapeutics Inc is negative because of negative EBITDA in last Financial Year , last Quarter and also in last twelve Months |
Other EBITDA Margin Related Info of JANX that may interest you.
Janux Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| JANX | 53.5 | 50.41 | 6.13 % | Biotechnology |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..
EBITDA Margin Related Ratios
| NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
| Poor Profitability Stock | |
FY - Historical EBITDA Margin of Janux Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 |
|---|---|---|---|---|---|
| EBITDA Margin | -717.76 | -747.81 | -898.32 | -1727.63 | 0 |
| Change | 4.02 % | 16.76 % | 48.00 % |
FY Chart of EBITDA Margin of Janux Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)